Heart Septal Defects, Ventricular: Clinical Trials

57 trials for Heart Septal Defects, Ventricular, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

35 completed, 5 recruiting, 5 unknown, 4 terminated. 16 Not applicable, 5 Phase 2, 4 Phase 1, 3 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable16Completed 11, Not yet recruiting 2, Recruiting 1, Unknown 1, Withdrawn 1
Phase 25Completed 4, Active not recruiting 1
Phase 14Completed 2, Recruiting 1, Withdrawn 1
Phase 33Terminated 2, Completed 1
Phase 42Completed 2
Early Phase 11Completed 1

Follow Heart Septal Defects, Ventricular: new trials by email Literature Review of Heart Septal Defects, Ventricular trials Research Report on Heart Septal Defects, Ventricular

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IABP for MI-VSD Patients in SCAI SHOCK Stage B
Insertion of IABP in SCAI SHOCK stage B - Acute Myocardial Infarction (AMI), Ventricular Septal Defects (VSD)
Not applicableNot yet recruitingQilu Hospital of Shandong University1002026-02-282026-03-19
Bypass Clear Priming VSD Cardiopulmonary Bypass Circuit Reduce Bypass Associated Inflammation?
Clear priming of the bypass pump - Ventricular Septal Defect
Not applicableNot yet recruitingSeattle Children's Hospital602026-02-252026-02-06
A Multimodal AI Prediction Model for Complications After Transcatheter Closure of Perimembranous VSD in Children
Congenital Heart Disease (CHD), Ventricular Septal Defects (VSD)
RecruitingXinhua Hospital, Shanghai Jiao Tong University School of Medicine52492026-02-012026-08-05
Investigation of Tetralogy of Fallot in Neonates
corrective surgery within 28 days of birth, corrective surgery between 3-6 months of age - Tetralogy of Fallot (TOF), Pulmonary Stenosis
Not applicableRecruitingBeijing Anzhen Hospital1602025-03-012026-10-13
An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects
Transcatheter device closure of perimembranous ventricular septal defects (PmVSDs) - Perimembranous Ventricular Septal Defect
RecruitingFondation Hôpital Saint-Joseph20002025-01-012026-09-08
Mechanical Complications of Acute Myocardial Infarction: a Multicenter Prospective Study
Surgical treatment, Percutaneous treatment - Ventricular Septal Defect, Papillary Muscle Rupture
RecruitingMaastricht University Medical Center8002025-01-012025-05-11
Comparison of Dynamic Compliance and Airway Resistance in Pressure-Controlled Versus Volume-Controlled Ventilation in Children Undergoing Corrective Heart Surgery
Pressure Controlled Ventilation, Volume Controlled Ventilation - Atrial Septal Defect, Ventricular Septal Defects
Not applicableCompletedNilratan Sircar Medical College722024-07-132026-08-10
Clinical Evaluation Of Ventricular Septal Defect (VSD) In Children at Sohag Univesity Hospital
ECHO - Ventricular Septal Defect
UnknownSohag University1002024-06-242024-07-09
The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease
Thiamine - Congenital Heart Disease, Thiamine Deficiency
Early Phase 1CompletedUniversitas Sumatera Utara862024-05-012026-03-24
Immune Heterogeneity Before and After Cardiopulmonary Bypass in Children
Ventricular Septal Defect
CompletedThe Children's Hospital of Zhejiang University School of Medicine32024-01-012025-03-11
Cera™ VSD Occluder Post Market Clinical Follow-up
Cera™ VSD occluder implantation - Ventricular Septal Defect
CompletedCardiac Children's Foundation Taiwan1522023-10-132025-06-12
Regional Anesthesia Following Pediatric Cardiac Surgery
Regional Anesthesia, Wound infiltration, Ropivacaine 0.2% Injectable Solution - Atrial Septal Defect, Ventricular Septal Defect
Phase 4CompletedDuke University522023-03-292025-08-28
Beta-blocker Administration for Cardiomyocyte Division
N-thymidine, Urine Collection, Echocardiogram - Tetralogy of Fallot, Double Outlet Right Ventricle
Phase 1RecruitingWeill Medical College of Cornell University402022-12-162025-11-18
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
L-citrulline, Plasmalyte A - Ventricular Septal Defect, Atrioventricular Septal Defect
Phase 3TerminatedAsklepion Pharmaceuticals, LLC642022-06-292024-09-19
Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period
Normoxia (with controlled re-oxygenation), Standard of care ventilation - Hypoplastic Left Heart Syndrome, Total Anomalous Pulmonary Venous Return
Not applicableCompletedUniversity of Michigan292021-01-182024-06-18
Prediction Model of Spontaneous Closure of Congenital Perimembranous Ventricular Septal Defects
Ventricular Septal Defects
WithdrawnXinhua Hospital, Shanghai Jiao Tong University School of Medicine2020-10-012026-08-03
Improving Care for Children With Congenital Heart Disease.
Biomarker analysis at enrolment, Biomarker analyses throughout the study - Heart Disease Congenital, Ventricular Septal Defect
Not applicableCompletedLund University Hospital3132020-02-172026-05-08
Optical Tissue Identification for Myocardial Architecture
Fluorescite, Cellvizio 100 Series System with Confocal Miniprobes - Ventricular Septal Defect, Complete Atrioventricular Canal
Phase 2Active not recruitingAditya Kaza702019-12-202023-06-15
Lifetech KONAR MFO Post-Market Clinical Follow-Up Study
KONAR-MF™ VSD Occluder - Ventricular Septal Defect
CompletedLifetech Scientific (Shenzhen) Co., Ltd.402019-12-042024-04-15
A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure
Fully Absorbable VSD Occlusion System, VSD Occluder - Ventricular Septal Defect
Not applicableUnknownChinese Academy of Medical Sciences, Fuwai Hospital1082019-04-112019-05-08

Showing 20 of 57. Sign in to see all of them.

Narrower conditions

Heart Defects, Congenital (21)  ·  Heart Septal Defects, Atrial (10)  ·  Double Outlet Right Ventricle (7)  ·  Tetralogy of Fallot (7)  ·  Transposition of Great Vessels (6)  ·  Atrioventricular Septal Defect (5)  ·  Cardiovascular Diseases (5)  ·  Endocardial Cushion Defects (5)  ·  Heart Diseases (4)  ·  Ductus Arteriosus, Patent (3)  ·  Heart Septal Defects (3)  ·  Pulmonary Valve Stenosis (3)  ·  Truncus Arteriosus, Persistent (3)  ·  Hypertension, Pulmonary (2)

Broader conditions

Congenital Abnormalities (57)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (57)  ·  Cardiovascular Abnormalities (56)  ·  Heart Septal Defects (54)  ·  Heart Diseases (53)  ·  Cardiovascular Diseases (52)  ·  Heart Defects, Congenital (36)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Pathologic Processes (7)  ·  Vascular Diseases (6)  ·  Transposition of Great Vessels (5)  ·  Heart Valve Diseases (4)  ·  Lung Diseases (4)  ·  Respiratory Tract Diseases (4)

Interventions

Dexmedetomidine (2)  ·  Surgical Procedures, Operative (2)  ·  Acetaminophen (1)  ·  Aging (1)  ·  Albuterol (1)  ·  Anesthesia, Conduction (1)  ·  Cardiac Surgical Procedures (1)  ·  Cardiopulmonary Bypass (1)  ·  Carnitine (1)  ·  Citrulline (1)  ·  Conversion to Open Surgery (1)  ·  Enalapril (1)  ·  Exercise Test (1)  ·  Fentanyl (1)  ·  Fluorescein (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (4)  ·  University of Aarhus (4)  ·  Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (3)  ·  Abbott Medical Devices (2)  ·  Asklepion Pharmaceuticals, LLC (2)  ·  Children's Healthcare of Atlanta (2)  ·  Kayseri City Hospital (2)  ·  National Taiwan University Hospital (2)  ·  Aditya Kaza (1)  ·  Arkansas Children's Hospital Research Institute (1)  ·  Beijing Anzhen Hospital (1)  ·  Bentong Yu (1)  ·  Boston Children's Hospital (1)  ·  Cardiac Children's Foundation Taiwan (1)  ·  Carelon Research (1)

Countries

United States (21)  ·  China (8)  ·  Denmark (5)  ·  Germany (5)  ·  Taiwan (3)  ·  Turkey (Türkiye) (3)  ·  Canada (2)  ·  Egypt (2)  ·  France (2)  ·  Indonesia (2)  ·  Italy (2)  ·  Sweden (2)  ·  Belarus (1)  ·  Belgium (1)  ·  Hong Kong (1)

Top investigators

Ronald Lauer (2)  ·  Aditya K Kaza, MD (1)  ·  Adnan T Bhutta, MD (1)  ·  Allan Doctor, MD (1)  ·  Andrew Redington, MD, DMSc, Prof. (1)  ·  Aymen N Naguib, MD (1)  ·  Bentong Yu, MD (1)  ·  Bernhard Kuhn, MD (1)  ·  Brian Kogon, MD (1)  ·  Britta Butzbach, MD (1)  ·  Catherine A. Leitch (1)  ·  Catherine Krawczeski, MD (1)  ·  Christopher Mastropietro, MD, FCCM (1)  ·  Chun-An Chen, MD, PhD (1)  ·  Daniel Levi, MD (1)

Results publications

PMID 18442545, PMID 19064683, PMID 19808531, PMID 19856409, PMID 20495149, PMID 20513701, PMID 20801925, PMID 21163497, PMID 21315203, PMID 21875911, PMID 21908707, PMID 21926656, PMID 22157844, PMID 22730421, PMID 22920912, PMID 24132714, PMID 24509270, PMID 26715570, PMID 26796197, PMID 28886621, PMID 29643872, PMID 30233808, PMID 31623840, PMID 32291090, PMID 32519889, PMID 33032536, PMID 33157063, PMID 34265312, PMID 34551835, PMID 35115207, PMID 37548158, PMID 40014670, PMID 40939873, PMID 41032451, PMID 42083863

NIH funding

2019 (1), 5UL1TR002240-05 (1), P50HL042266 (1), P50HL062178 (1), R01HL039052 (1), R01HL041786 (1), R01HL155597 (1), R56HL128813 (1), U01HL068269 (1), U01HL068270 (1), U01HL068279 (1), U01HL068281 (1), U01HL068285 (1), U01HL068288 (1), U01HL068290 (1)